Warning for companies about confidentiality agreements

Many companies, particularly in the manufacturing and investment industries, often receive unsolicited ideas. Perhaps your company has experienced this. The discloser assures you that he’s got a million-dollar idea, but he wants you to enter a confidentiality...

Using Article 19 and Article 34 in patent amendments

After a PCT applicant receives a search report and written opinion, he may wish to respond to the Examiner’s comments “on the record.” There are two ways this can be done – under Article 19 (Chapter I) or under Article 34 (Chapter II). Let’s compare these two...

Racing to the patent office

The AIA has started a race to the patent office.  This will be especially true for technologies where several inventors, research teams or companies are working to solve a similar problem. In the end, it will be more of a marathon for many inventors. Inventors who are...

Pre-patent disclosure of your invention

There are many times that you need to disclose information about your inventive concept to third parties such as vendors, contractors and investors. The best possible protection is to have a patent application filed before any such disclosures are made so that there...

New PCT country: Israel

Israel began a pilot PPH program on August 1, 2012. This is great news for biotech and pharmaceutical patentees, since there is significant pharmaceutical manufacturing in Israel. WIPO actually agreed in 2009 to allow the Israeli Patent Office (IPO) to acts as an...